Neoantigen-Specific Immunotherapy
1 clinical trials · Condition
◉ Watch Neoantigen-Specific Immunotherapy
| Record | Firm | Date |
|---|---|---|
| Personalized Neoantigen Peptide Vaccines for Solid Tumors (NCT07002203) | Seqker Biosciences, Inc. | 2024-03-01 |
Track Neoantigen-Specific Immunotherapy automatically
Every clearance here is in the API, with alerts when new ones post.